Literature DB >> 23057493

Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.

David Oscier1, Claire Dearden, Efrem Eren, Efrem Erem, Christopher Fegan, George Follows, Peter Hillmen, Tim Illidge, Estella Matutes, Don W Milligan, Andrew Pettitt, Anna Schuh, Jennifer Wimperis.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23057493     DOI： 10.1111/bjh.12067

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  41 in total

1.  Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy.

Authors:  Andrea Visentin; Nicolò Compagno; Francesco Cinetto; Silvia Imbergamo; Renato Zambello; Francesco Piazza; Gianpietro Semenzato; Livio Trentin; Carlo Agostini
Journal:  Haematologica       Date:  2015-08-20       Impact factor: 9.941

2.  Primary care management of early stage chronic lymphocytic leukaemia is safe and effective.

Authors:  H M Parry; S Damery; N P Mudondo; P Hazlewood; T McSkeane; S Aung; J Murray; G Pratt; P Moss; D W Milligan
Journal:  QJM       Date:  2015-01-31

3.  Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Hossein Khiabanian; Valeria Spina; Carmela Ciardullo; Alessio Bruscaggin; Rosella Famà; Silvia Rasi; Sara Monti; Clara Deambrogi; Lorenzo De Paoli; Jiguang Wang; Valter Gattei; Anna Guarini; Robin Foà; Raul Rabadan; Gianluca Gaidano
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

Review 4.  Evolving understanding of the CLL genome.

Authors:  Michaela Gruber; Catherine J Wu
Journal:  Semin Hematol       Date:  2014-05-15       Impact factor: 3.851

Review 5.  Management of chronic lymphocytic leukemia.

Authors:  Paolo Ghia; Michael Hallek
Journal:  Haematologica       Date:  2014-06       Impact factor: 9.941

Review 6.  Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

Authors:  Mohamed A Kharfan-Dabaja; Ambuj Kumar; Mehdi Hamadani; Stephan Stilgenbauer; Paolo Ghia; Claudio Anasetti; Peter Dreger; Emili Montserrat; Miguel-Angel Perales; Edwin P Alyea; Farrukh T Awan; Ernesto Ayala; Jacqueline C Barrientos; Jennifer R Brown; Januario E Castro; Richard R Furman; John Gribben; Brian T Hill; Mohamad Mohty; Carol Moreno; Susan O'Brien; Steven Z Pavletic; Javier Pinilla-Ibarz; Nishitha M Reddy; Mohamed Sorror; Christopher Bredeson; Paul Carpenter; Bipin N Savani
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-19       Impact factor: 5.742

7.  Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?

Authors:  Reem Alsolami; Samantha Jl Knight; Anna Schuh
Journal:  Per Med       Date:  2013-06-01       Impact factor: 2.512

8.  Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia.

Authors:  C Owen; A S Gerrie; V Banerji; S Assouline; C Chen; K S Robinson; E Lye; G Fraser
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

9.  Consistency of the Moreau CLL score.

Authors:  Marc Sorigue; Edurne Sarrate; Mireia Franch-Sarto; Evarist Feliu; Jordi Junca
Journal:  J Clin Lab Anal       Date:  2017-12-28       Impact factor: 2.352

Review 10.  Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?

Authors:  Fatima Dhalla; Mary Lucas; Anna Schuh; Malini Bhole; Rashmi Jain; Smita Y Patel; Siraj Misbah; Helen Chapel
Journal:  J Clin Immunol       Date:  2014-02-21       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.